Blood group phenotypes resulting from mutations in erythroid transcription factors

Current Opinion in Hematology

Volumn 19, Issue 6, 2012, Pages 486-493

  Singleton, Belinda K ^a   Frayne, Jan ^a   Anstee, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

erythroid transcription factor; GATA1; KLF1; Lutheran blood group; red blood cells

Indexed keywords

AQUAPORIN 1; BLOOD GROUP ANTIGEN; DNA; ERYTHROID KRUPPEL LIKE FACTOR; HEMOGLOBIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN DELTA CHAIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; KRUPPEL LIKE FACTOR 1; PROTOPORPHYRIN ZINC; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACANTHOCYTOSIS; ANEMIA; ANTIGEN EXPRESSION; BETA THALASSEMIA; BLOOD GROUP; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP SYSTEM; CENTROMERE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CONSENSUS SEQUENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA BINDING; DNA SEQUENCE; DYSERYTHROPOIESIS; ERYTHROCYTE; ERYTHROCYTE DISORDER; ERYTHROPOIESIS; EXON; GENE CONTROL; GENE MUTATION; GENETIC REGULATION; GENOTYPE; GLOBIN GENE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HUMAN; IN VITRO STUDY; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVIEW; SUPPRESSOR GENE; THROMBOCYTOPENIA; VASCULAR ENDOTHELIUM; X CHROMOSOME; ZINC FINGER MOTIF;

BLOOD GROUP ANTIGENS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUTATION; PHENOTYPE;

EID: 84868191127     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328358f92e     Document Type: Review

References (59)

1. Parsons SF, Mallinson G, Holmes CH, et al. The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 1995; 92:5496-5500.
2. Parsons SF, Lee G, Spring FA, et al. Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity. Blood 2001; 97:312-320.
3. El Nemer W, Gane P, Colin Y, et al. Characterization of the laminin binding domains of the Lutheran blood group glycoprotein. J Biol Chem 2001; 276:23757-23762.
4. El Nemer W, Colin Y, Le Van Kim C. Role of Lu/BCAM glycoproteins in red cell diseases. Transfus Clin Biol 2010; 17:143-147.
5. Brown F, Simpson S, Cornwall S, et al. The recessive Lu(a-b-) phenotype: a family study. Vox Sang 1974; 26:259-264.
6. Karamatic Crew V, Mallinson G, Green C, et al. Different inactivating mutations in the LU genes of three individuals with the Lutheran-null phenotype. Transfusion 2007; 47:492-498.
7. Crawford MN, Greenwalt TJ, Sasaki T, et al. The phenotype Lu(a-b-) together with unconventional Kidd groups in one family. Transfusion 1961; 1:228-232.
8. Norman PC, Tippett P, Beal RW. A Lu(a-b-) phenotype caused by an Xlinked recessive gene. Vox Sang 1986; 51:49-52.
9. Taliano V, Gué vin R-M, Tippett P. The genetics of a dominant inhibitor of the Lutheran antigens. Vox Sang 1973; 24:42-47.
10. Shaw MA, Leak MR, Daniels GL, Tippett P. The rare Lutheran blood group phenotype Lu(a-b-): a genetic study. Ann Hum Genet 1984; 48:229-237.
11. Rowe GP, Gale SA, Daniels GL, et al. A study on Lu-null families in South Wales. Ann Hum Genet 1992; 56:267-272.
12. Telen MJ. Lutheran antigens, CD44-related antigens, and Lutheran regulatory genes. Transfus Clin Biol 1995; 2:291-301.
13. Udden MM, Umeda M, Hirano Y, Marcus DM. New abnormalities in the morphology, cell surface receptors, and electrolyte metabolism of In(Lu) erythrocytes. Blood 1987; 69:52-57.
14. Ballas SK, Marcolina MJ, Crawford MN. In vitro storage and in vivo survival studies of red cells from persons with the In(Lu) gene. Transfusion 1992; 32:607-611.
15. Mulley JC, Norman PC, Tippett P, Beal RW. A regional localisation for an Xlinked suppressor gene (XS) for the Lutheran blood group. Hum Genet 1988; 78:127-129.
16. Wickramasinghe SN, Illum N, Wimberley PD. Congenital dyserythropoietic anaemia with novel intra-erythroblastic and intra-erythrocytic inclusions. Br J Haematol 1991; 79:322-330.
17. Tang W, Cai SP, Eng B, et al. Expression of embryonic zeta-globin and epsilon-globin chains in a 10-year-old girl with congenital anemia. Blood 1993; 81:1636-1640.
18. Parsons SF, Jones J, Anstee DJ, et al. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)]. Blood 1994; 83:860-868.
19. Agre P, Smith BL, Baumgarten R, et al. Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia. J Clin Invest 1994; 94:1050-1058.
20. Nuez B, Michalovich D, Bygrave A, et al. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995; 375:316-318.
21. Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 1995; 375:318-322.
22. Perkins AC, Gaensler KM, Orkin SH. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci USA 1996; 93:12267-12271.
23. Tallack MR, Perkins AC. KLF1 directly coordinates almost all aspects of terminal erythroid differentiation. IUBMB Life 2010; 62: 886-890.
24. Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood 2011; 118:2044-2054.
25. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Mol Cell Biol 1993; 13:2776-2786.
26. Feng WC, Southwood CM, Bieker JJ. Analyses of beta-thalassemia mutant DNA interactions with erythroid Kruppel-like factor (EKLF), an erythroid cell-specific transcription factor. J Biol Chem 1994; 269: 1493-1500.
27. Orkin SH, Kazazian HH Jr, Antonarakis SE, et al. Linkage of betathalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 1982; 296: 627-631.
28. Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008; 112:2081-2088.
29. Giardine B, Borg J, Higgs DR, et al. Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. Nat Genet 2011; 43:295-301.
30. Gallienne AE, Dreau HMP, Schuh A, et al. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica 2012; 97:340-343.
31. Satta S, Perseu L, Moi P, et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica 2011; 96:767-770.
32. Perseu L, Satta S, Demartis FR, et al. KLF1 gene mutations cause borderline HbA2. Blood 2011; 118:4454-4458.
33. Satta S, Perseu L, Maccioni L, et al. Delayed fetal hemoglobin switching in subjects with KLF1 gene mutation. Blood Cells Mol Dis 2012; 48:22-24.
34. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010; 42:801-905.
35. Singleton BK, Fairweather VSS, Lau W, et al. A novel EKLF mutation in a patient with dyserythropoietic anemia: the first association of EKLF with disease in man. Blood (ASH Annual Meeting Abstracts) 2009; 114:Abstract 162.
36. Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet 2010; 87:721-727.
37. Singleton BK, Lau W, Fairweather VS, et al. Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes. Blood 2011; 118:3137-3145.
38. Ravindranath Y, Goyette G, Buck S, et al. A new case of KLF1 G973A mutation and congenital dyserythropoietic anemia (CDA): further definition of emerging new syndrome and possible association with gonadal dysgenesis. Blood (ASH Annual Meeting Abstracts) 2011; 118:Abstract 2101.
39. Mitchell WB, Gnanapragasam MN, Jaffray JA, et al. Case report of erythroid transcription factor EKLF mutation causing a rare form of congenital dyserythropoietic anemia in a patient of Taiwanese origin. Blood (ASH Annual Meeting Abstracts) 2011; 118:Abstract 2154.
40. Siatecka M, Sahr KE, Andersen SG, et al. Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor. Proc Natl Acad Sci USA 2010; 107:15151-15156.
41. Heruth DP, Hawkins T, Logsdon DP, et al. Mutation in erythroid specific transcription factor KLF1 causes hereditary spherocytosis in the Nan hemolytic anemia mouse model. Genomics 2010; 96:303-307.
42. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005; 16:137-147.
43. Ferreira R, Ohneda K, YamamotoM, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005; 25:1215-1227.
44. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80:575-581.
45. Welch JJ, Watts JA, Vakoc CR, et al. Global regulation of erythroid gene expression by transcription factor GATA-1.
46. Tsang AP, Visvader JE, Turner CA, et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 1997; 90:109-119.
47. Cheng Y, Wu W, Kumar SA, et al. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 2009; 19:2172-2184.
48. Wontakal SN, Guo X, Smith C, et al. A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation. Proc Natl Acad Sci USA 2012; 109:3832-3837.
49. Kaneko H, Kobayashi E, Yamamoto M, Shimizu R. N-and C-terminal transactivation domains of GATA1 coordinate the hematopoietic program. J Biol Chem 2012; 287:21439-21449.
50. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24:266-270.
51. Ciovacco WA, Raskind WH, Kacena MA. Human phenotypes associated with GATA-1 mutations. Gene 2008; 427:1-6.
52. Singleton BK, Roxby D, Stirling J, et al. A novel GATA1 mutation (Ter414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype. Blood (ASH Annual Meeting Abstracts) 2009; 114:Abstract 1979.
53. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008; 322:1839-1842.
54. Zhou D, Liu K, Sun C-W, et al. KLF1 regulates BCL11A expression and gamma-to beta-globin gene switching. Nat Genet 2010; 42:742-744.
55. Moi P, MariniGM, Asunis I, et al. HPFH from Klf1 haploinsufficiency combined to transcriptional heterozygous b-thalassemia. Blood (ASH Annual Meeting Abstracts) 2011; 118:Abstract 2151.
56. Sankaran VG, Xu J, Orkin SH. Advances in the understanding of haemoglobin switching. Br J Haematol 2010; 149:181-194.
57. Felice AE, Galdies R, Borg J, et al. Does quantitative heterogeneity of human fetal hemoglobin (HbF) reveal friends or foes of KLF1 in globin gene switching? Blood (ASH Annual Meeting Abstracts) 2011; 118:Abstract 1092.
58. Gallagher PG. HbA2: at the borderline of the KLF. Blood 2011; 118:4301-4302.
59. Borg J, Patrinos GP, Felice AE, Philipsen S. Erythroid phenotypes associated with KLF1 mutations. Hematologica 2011; 96:635-638.